Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • abbott

    Tag: abbott

    You Searched For "abbott"
    NPPA says Abbott can discontinue Xience Alpine stent in a year, check out details

    NPPA says Abbott can discontinue Xience Alpine stent in a year, check out details

    Ruby Khatun Khatun27 Sep 2017 7:12 AM GMT
    New Delhi: Through a recent notice, Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
    NPPA allows Abbott to withdraw bioresorbable stent from India

    NPPA allows Abbott to withdraw bioresorbable stent from India

    Ruby Khatun Khatun22 Sep 2017 11:30 AM GMT
    New Delhi: Through a recent notice, Government of India , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
    Abbott pulls back its bioresorbable stent-ABSORB, also moves to withdraw XIENCE from India

    Abbott pulls back its bioresorbable stent-ABSORB, also moves to withdraw XIENCE from India

    Ruby Khatun Khatun11 Sep 2017 9:47 AM GMT
    New Delhi: Abbott has taken up the decision to stop the sales of sales of its bioresorbable coronary stent 'Absorb' globally due to low commercial...
    Abbott India Q1 net profit down 35 percent at Rs 48 crore

    Abbott India Q1 net profit down 35 percent at Rs 48 crore

    Ruby Khatun Khatun10 Aug 2017 3:46 AM GMT
    New Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended...
    4 more medical devices to be added to price control list, document shows

    4 more medical devices to be added to price control list, document shows

    Ruby Khatun Khatun7 Jun 2017 8:06 AM GMT
    New Delhi/Mumbai: India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for...
    Govt rejects Abbott, Medtronic applications to withdraw stents

    Govt rejects Abbott, Medtronic applications to withdraw stents

    Ruby Khatun Khatun27 April 2017 9:59 AM GMT
    New Delhi: The government on Wednesday rejected applications by multinational firms Abbott Healthcare Pvt Ltd and India Medtronic Pvt Ltd to withdraw t...
    Government Prohibits Stent companies to withdraw stents for Next Six Months

    Government Prohibits Stent companies to withdraw stents for Next Six Months

    Ruby Khatun Khatun25 April 2017 9:42 AM GMT
    New Delhi: In a bid to prevent Multinational Stent makers from removing their next generation stents from the Indian Market, the central government...
    After Abbott, two more Stent makers seek withdrawal of New Gen Stents

    After Abbott, two more Stent makers seek withdrawal of New Gen Stents

    Ruby Khatun Khatun24 April 2017 8:09 AM GMT
    MUMBAI: Soon after Abbott was seen seeking withdrawal of its withdraw two types of stents from the Indian market, reports are coming in that two more...
    Abbott decides to withdraw 2 stent types from India

    Abbott decides to withdraw 2 stent types from India

    supriya kashyap kashyap22 April 2017 4:17 AM GMT
    New Delhi : Healthcare major Abbott has decided to withdraw two types of stents from the Indian market in the wake of drug price regulator National...
    Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin

    Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin

    savita thakur thakur26 March 2017 6:03 AM GMT
    The Swiss drug maker Novartis and US based Abbott along with domestic companies Emcure and USV Pharma are under the lens of Health Ministry and...
    Abbott sales rep commits suicide, blames company in suicide note

    Abbott sales rep commits suicide, blames company in suicide note

    Geeta Sharma Sharma25 July 2016 12:17 PM GMT
    Mumbai:The suicide of Ashish Awasthi, the 35 year old sales representative found dead on a railway track in Indore has sparked both controversy...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 27 May 2022 6:45 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X